Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: The Rio de Janeiro Type 2 Diabetes Cohort Study

Journal of Hypertension

Volumn 31, Issue 11, 2013, Pages 2176-2186

  Salles, Gil F ^a   Leite, Nathalie C ^a   Pereira, Basílio B ^b   Nascimento, Emilia M ^b   Cardoso, Claudia R L ^a  

^a Department of Internal Medicine ^*  (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ambulatory blood pressures; arterial hypertension; mortality; prognosis; type 2 diabetes

Indexed keywords

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BRAZIL; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT ANALYSIS; COMPLICATION; EPIDEMIOLOGY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; BRAZIL; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84885637693     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328364103f     Document Type: Article

References (41)

1. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2002; 25 (suppl 1):S71-S73.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572.
3. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
4. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
5. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al., ACCORD Study Group. Effects of intensive bloodpressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585.
6. Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304:61-68.
7. Anderson RJ, Bahn GD, Moritz TE, Kaufman D, Abraira C, Duckworth W, for the VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care 2011; 34:34-38.
8. Reboldi G, Gentile G, Angeli F, Ambrosio G, Mancia G, Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: A meta-analysis in 73,913 patients. J Hypertens 2011; 29:1253-1269.
9. McBrien K, Rabi DM, Campbell N, Barnieh L, Clement F, Hemmelgarn BR, et al. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2012; 172:1296-1303.
10. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415.
11. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension 2005; 46:156-161.
12. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- BodegÄrd K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet 2007; 370:1219-1229.
13. Parati G, Bilo G. Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care 2009; 32 (Suppl 2):S298-S304.
14. Cardoso CR, Leite NC, Freitas L, Dias SB, Muxfeld ES, Salles GF. Pattern of 24-h ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy. Hypertens Res 2008; 31:865-872.
15. Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009; 205:472-476.
16. Salles GF, Teixeira GB, Leite NC, Muxfeldt ES, Cardoso CR. Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients. Hypertens Res 2010; 33:819-824.
17. Cardoso CR, Leite NC, Muxfeldt ES, Salles GF. Thresholds of ambulatory blood pressure associated with chronic complications in type 2 diabetes. Am J Hypertens 2012; 25:82-88.
18. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 2000; 5:233-238.
19. American Diabetes Association. Standards of medical care in Diabetes. Diabetes Care 2005; 28 (suppl 1):S4-S36.
20. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-935.
21. D'Agostino RB. Beyond baseline data: the use of time-varying covariates. J Hypertens 2008; 26:639-640.
22. Concato J, Feinstein AR, Holford TR. The risk of determining risk in multivariate models. Ann Intern Med 1993; 118:201-210.
23. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al., European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701.
24. Cooper-DeHoff RM, Egelund EF, Pepine CJ. Blood pressure in patients with diabetes: one level might not fit all. Nat Rev Cardiol 2011; 8:42-49.
25. Elliott WJ. What should be the blood pressure target for diabetic patients? Curr Opin Cardiol 2011; 26:308-313.
26. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-713.
27. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351:1755-1762.
28. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with noninsulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:645-652.
29. ADVANCE Collaborative Group. Effect of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes (the ADVANCE trial): A randomized controlled trial. Lancet 2007; 370:829-840.
30. Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation 2011; 124:1727-1736.
31. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the national health interview survey. Diabetes Care 2012; 35:1252-1257.
32. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47:1501-1506.
33. Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Nondipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med 2000; 17:360-364.
34. Nakano S, Konishi K, Furuya K, Uehara K, Nishizawa M, Nakagawa A, et al. A prognostic role of mean 24-h pulse pressure level for cardiovascular events in type 2 diabetic subjects under 60 years of age. Diabetes Care 2005; 28:95-100.
35. Mannucci E, Lambertucci L, Monami M, Fedeli A, Chiasserini V, Marchionni N, et al. Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study. Diabetes Metab Res Rev 2006; 22:172-175.
36. Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: A follow-up study. J Hypertens 2007; 25:2479-2485.
37. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz JE, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 2008; 21:443-450.
38. Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab 2008; 34:560-567.
39. Palmas W, Pickering TG, Teresi J, Schwartz JE, Moran A, Weinstock RS, Shea S. Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension 2009; 53:120-127.
40. Kikuya M, Hansen TW, Thijs L, Björklund-BodegÄrd K, Kuznetsova T, Ohkubo T, et al., International Database on Ambulatory blood pressure monitoring in relation to CardiovascularOutcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115:2145-2152.
41. Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 2011; 34:1270-1276.